OS of patients with MDS/MPN with neutrophilia in the Netherlands, from 2001 to 2019. The panels show the OS of patients with MDS/MPN with neutrophilia diagnosed during 2001 to 2019 (A) overall and according to (B) sex, (C) calendar period of diagnosis, (D) age at diagnosis, and (E) primary therapy in broad categories. The median OS and the 1-, 5-, and 10-year OS according to the characteristics shown in panels A-E are presented in supplemental Table 2. alloSCT, allogeneic stem cell transplantation; Tx, therapy; w/o, without.